BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10428078)

  • 1. Selective blocking effects of tropisetron and atropine on recombinant glycine receptors.
    Maksay G; Laube B; Betz H
    J Neurochem; 1999 Aug; 73(2):802-6. PubMed ID: 10428078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
    Maksay G
    Neuropharmacology; 1998 Dec; 37(12):1633-41. PubMed ID: 9886686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different binding modes of tropeines mediating inhibition and potentiation of alpha1 glycine receptors.
    Maksay G; Laube B; Schemm R; Grudzinska J; Drwal M; Betz H
    J Neurochem; 2009 Jun; 109(6):1725-32. PubMed ID: 19383091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropisetron modulation of the glycine receptor: femtomolar potentiation and a molecular determinant of inhibition.
    Yang Z; Ney A; Cromer BA; Ng HL; Parker MW; Lynch JW
    J Neurochem; 2007 Feb; 100(3):758-69. PubMed ID: 17181559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine.
    Yamakura T; Chavez-Noriega LE; Harris RA
    Anesthesiology; 2000 Apr; 92(4):1144-53. PubMed ID: 10754635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptor beta subunits play a critical role in potentiation of glycine responses by ICS-205,930.
    Supplisson S; Chesnoy-Marchais D
    Mol Pharmacol; 2000 Oct; 58(4):763-70. PubMed ID: 10999946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory Actions of Tropeines on the α3 Glycine Receptor Function.
    San Martín VP; Burgos CF; Marileo AM; Lara CO; Sazo A; Fuentealba J; Guzmán L; Castro PA; Aguayo LG; Moraga-Cid G; Yévenes GE
    Front Pharmacol; 2019; 10():331. PubMed ID: 31024303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha9 nicotinic acetylcholine receptor shares pharmacological properties with type A gamma-aminobutyric acid, glycine, and type 3 serotonin receptors.
    Rothlin CV; Katz E; Verbitsky M; Elgoyhen AB
    Mol Pharmacol; 1999 Feb; 55(2):248-54. PubMed ID: 9927615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gating effects on picrotin block of glycine receptors.
    Li P; Slaughter MM
    Neuroreport; 2012 Dec; 23(17):1017-20. PubMed ID: 23079787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
    Pistis M; Belelli D; Peters JA; Lambert JJ
    Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors.
    Klein RL; Sanna E; McQuilkin SJ; Whiting PJ; Harris RA
    Eur J Pharmacol; 1994 Jul; 268(2):237-46. PubMed ID: 7957645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of tropeines and allosteric modulation of ionotropic glycine receptors.
    Maksay G; Nemes P; Bíró T
    J Med Chem; 2004 Dec; 47(25):6384-91. PubMed ID: 15566307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicuculline antagonizes 5-HT(3A) and alpha2 glycine receptors expressed in Xenopus oocytes.
    Sun H; Machu TK
    Eur J Pharmacol; 2000 Mar; 391(3):243-9. PubMed ID: 10729364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.
    Laube B; Kuhse J; Betz H
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):215-30. PubMed ID: 10639099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of 3-[2-phosphonomethyl[1,1-biphenyl]-3-yl]alanine (PMBA) on cloned glycine receptors.
    Hosie AM; Akagi H; Ishida M; Shinozaki H
    Br J Pharmacol; 1999 Mar; 126(5):1230-6. PubMed ID: 10205013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
    Lochner M; Thompson AJ
    Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual cooperative allosteric modulation of binding to ionotropic glycine receptors.
    Maksay G; Bíró T
    Neuropharmacology; 2002 Dec; 43(7):1087-98. PubMed ID: 12504915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding-site mutations in the alpha1 subunit of the inhibitory glycine receptor convert the inhibitory metal ion Cu2+ into a positive modulator.
    Schumann T; Grudzinska J; Kuzmin D; Betz H; Laube B
    Neuropharmacology; 2009 Jan; 56(1):310-7. PubMed ID: 18793654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta subunit increases the ginkgolide B sensitivity of inhibitory glycine receptors.
    Kondratskaya EL; Betz H; Krishtal OA; Laube B
    Neuropharmacology; 2005 Nov; 49(6):945-51. PubMed ID: 16125206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.